Home > Insider Trading > Filing (0001225208-17-013448)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
701221	Cigna Corp	CI	Hospital & Medical Service Plans (6324)	061059331

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1554974	D Jason Sadler	900 Cottage Grove Road Bloomfield CT 06002	Pres., International Markets	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $.25 Par Value	Acquisiton	2017-08-07	13,340	$78.04	47,844	No	4	M	Direct
Common Stock, $.25 Par Value	Acquisiton	2017-08-07	10,534	$120.90	58,378	No	4	M	Direct
Common Stock, $.25 Par Value	Acquisiton	2017-08-07	4,864	$58.73	63,242	No	4	M	Direct
Common Stock, $.25 Par Value	Acquisiton	2017-08-07	4,562	$139.22	67,804	No	4	M	Direct
Common Stock, $.25 Par Value	Disposition	2017-08-07	37,756	$176.16	30,048	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, $.25 Par Value	Employee Stock Option (Right to Buy)	Disposition	2017-08-07	10,534	$0.00	10,534	$120.90
Common Stock, $.25 Par Value	Employee Stock Option (Right to Buy)	Disposition	2017-08-07	13,340	$0.00	13,340	$78.04
Common Stock, $.25 Par Value	Employee Stock Option (Right to Buy)	Disposition	2017-08-07	4,562	$0.00	4,562	$139.22
Common Stock, $.25 Par Value	Employee Stock Option (Right to Buy)	Disposition	2017-08-07	4,864	$0.00	4,864	$58.73

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,268	2016-02-25	2025-02-25	No	4	M	Direct
0	2015-02-26	2024-02-26	No	4	M	Direct
9,124	2017-03-01	2026-03-01	No	4	M	Direct
0	2014-03-05	2023-03-05	No	4	M	Direct

Footnotes

Represents the weighted average price of the shares sold. The prices actually received ranged from $175.89 to $176.44 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
This option vests in three equal annual installments. The first installment became exercisable on February 25, 2016, the second installment became exercisable on February 25, 2017, and the last installment becomes exercisable on February 25, 2018.
This option was granted on February 26, 2014. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.
This option vests in three equal annual installments. The first installment became exercisable on March 1, 2017, and the next two installments become exercisable on March 1, 2018 and March 1, 2019.
This option was granted on March 5, 2013. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.